Klenner Mitchell A, Zhang Bo, Ciancaleoni Gianluca, Howard James K, Maynard-Casely Helen E, Clegg Jack K, Massi Massimiliano, Fraser Benjamin H, Pascali Giancarlo
Human Health & National Deuteration Facility, Australian Nuclear Science and Technology Organisation (ANSTO) Lucas Heights NSW 2234 Australia
School of Molecular and Life Sciences, Curtin University Bentley WA 6102 Australia.
RSC Adv. 2020 Feb 28;10(15):8853-8865. doi: 10.1039/d0ra00318b. eCollection 2020 Feb 27.
A novel fluorine-18 method employing rhenium(i) mediation is described herein. The method was found to afford moderate to high radiochemical yields of labelled rhenium(i) complexes. Subsequent thermal dissociation of the complexes enabled the radiosynthesis of fluorine-18 labelled pyridine bidentate structures which could not be radiofluorinated hitherto. This rhenium(i) complexation-dissociation strategy was further applied to the radiosynthesis of [F]CABS13, an Alzheimer's disease imaging agent, alongside other 2,2'-bipyridine, 1,10-phenanthroline and 8-hydroxyquinoline labelled radiotracers. Computational modelling of the reaction mechanism suggests that the efficiency of rhenium(i) activation may be attributed to both an electron withdrawal effect by the metal center and the formation of an acyl fluoride intermediate which anchors the fluoride subsequent to nucleophilic addition.
本文描述了一种采用铼(I)介导的新型氟 - 18方法。该方法被发现能提供中等至高的放射性化学产率的标记铼(I)配合物。配合物随后的热解离使得能够放射合成迄今无法进行放射性氟化的氟 - 18标记的吡啶双齿结构。这种铼(I)络合 - 解离策略进一步应用于阿尔茨海默病显像剂[F]CABS13的放射合成,以及其他2,2'-联吡啶、1,10 - 菲咯啉和8 - 羟基喹啉标记的放射性示踪剂。反应机理的计算模型表明,铼(I)活化的效率可能归因于金属中心的吸电子效应以及亲核加成后锚定氟化物的酰氟中间体的形成。